Newswire

STAT+ A U.S. judge has struck down a Trump administration rule that allowed health insurers not to count copay assistance offered by drug...

The Hill | Opinion When it comes to the alphabet soup of acronyms in health care, it can be hard to keep up. Whether it is the difference...

The State Journal From my University of Kentucky College of Pharmacy graduation, to beginning a new job at the Kentucky Pharmacists...

All measures would require more transparency about the fees they collect MedPage Today Confused by all the bills being introduced in...

Vote withdraws 11 letters, reports supporting PBMs Industry group argues pharmacy benefit market is ‘dynamic’ Bloomberg Law The FTC voted...

Policy from 2000s put PBMs in ‘regulatory free zone’ Push for oversight of the companies heats up Bloomberg Law The FTC on Thursday plans...

American Economic Liberties Project During the first half of an oversight hearing in the House Judiciary Committee today, a bipartisan...

Modern Healthcare Reporter: LAUREN BERRYMAN Yet another congressional committee has advanced legislation aimed at bringing down...

The New York Times The Times reported last month that drug shortages in the United States are approaching record levels, with thousands...

The Washington Examiner Members of both parties on the House Committee on Oversight and Accountability expressed support for the...

Round of subpoenas is the latest attempt to pierce industry Entities allow PBMs to ‘hide the ball,’ consultant says Bloomberg US...

KFF Health News Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is...

Axios Pro A Congressional panel unanimously advanced legislation with new transparency requirements for pharmacy benefit managers on...

Agency issues orders to companies affiliated with CVS Caremark, Express Scripts, and Prime Therapeutics as it examines the PBMs’ impact...

Drugmakers, prescription-drug middlemen trade jabs over high cost of medications MarketWatch A bipartisan effort to rein in prescription...

Forbes Today , Sen. Bernie Sanders, I-Vt., will haul executives from three insulin manufacturers and three pharmacy benefit managers...

STAT+ House Oversight Committee Chairman James Comer plans to hold a hearing on the results of an investigation into the business...

Healio Key takeaways: The bipartisan plan would decouple pharmacy benefit manager compensation from drug prices, among other reforms. The...

CT Mirror “I cannot afford to live.” – Patients are screaming at the outrageous prescription drug costs. The U.S. spends three times more...

Bipartisan Respondents Strongly Favor Policies that Require PBMs to Provide Value and Lower Drug Costs PBM Accountability Project With...